InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 36497

Thursday, 10/27/2016 12:09:49 PM

Thursday, October 27, 2016 12:09:49 PM

Post# of 48316
Using the biomarker assay the patients enrolled in Oncosec's combination trial with Keytruda are most likely to not respond to Keytruda monotherapy. That is the consensus and that is very much keeping it real according to scientific data.